New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
'Indian Diaspora Has Become A Living Example Of Co-Existence & Co-Operation': PM Modi In Muscat
'Banned’ Dhurandhar's FA9LA Song Played At Bilawal Bhutto's Party In Pakistan - VIDEO
'Students Proficient In Traditional Music Can Now Pursue Engineering At IIT-Madras': Director Prof. V. Kamakoti
Ahead of BMC Polls 2026, Eknath Shinde Rallies Shiv Sainiks Across North Mumbai, Calls for United Push
